Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Platelet Glycoprotein IIb / IIIa Inhibition and its Clinical Use
pp. 187-196(10)
Authors: Huang F.; Hong E.

The Adipose Tissue as a Source of Vasoactive Factors
pp. 197-208(12)
Authors: Frühbeck G.

Catalytic Features, Regulation and Function of Myocardial Phospholipase A2
pp. 209-218(10)
Authors: McHowat J.; Creer M.H.

Peptide Metabolism and the Control of Body Fluid Homeostasis
pp. 219-238(20)
Authors: Silveira P.F.; Gil J.; Casis L.; Irazusta J.

Novel Human Plasma Proteins, IHRP (Acute Phase Protein) and PHBP (Serine Protease), Which Bind to Glycosaminoglycans
pp. 239-248(10)
Author: Choi-Miura N..H.

Preconditioning of the Myocardium by Volatile Anesthetics
pp. 249-255(7)
Authors: Kwok W-M.; Aizawa K.

New Insights into the Intracellular Mechanisms by Which PGI2 Analogues Elicit Vascular Relaxation: Cyclic AMP-Independent, Gs-Protein Mediated-Activation of MaxiK Channel
pp. 257-265(9)
Authors: Tanaka Y.; Yamaki F.; Koike K.; Toro L.

Direct Antithrombins: New Perspectives in Cardiovascular Medicine
pp. 267-275(9)
Authors: Lettino M.; Toschi V.